These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 23572324

  • 1. Usefulness of dabigatran etexilate as periprocedural anticoagulation therapy for atrial fibrillation ablation.
    Yamaji H, Murakami T, Hina K, Higashiya S, Kawamura H, Murakami M, Kamikawa S, Hirohata S, Kusachi S.
    Clin Drug Investig; 2013 Jun; 33(6):409-18. PubMed ID: 23572324
    [Abstract] [Full Text] [Related]

  • 2. Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter.
    Kaiser DW, Streur MM, Nagarakanti R, Whalen SP, Ellis CR.
    J Interv Card Electrophysiol; 2013 Sep; 37(3):241-7. PubMed ID: 23625091
    [Abstract] [Full Text] [Related]

  • 3. Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature.
    Hohnloser SH, Camm AJ.
    Europace; 2013 Oct; 15(10):1407-11. PubMed ID: 23954917
    [Abstract] [Full Text] [Related]

  • 4. Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
    Lakkireddy D, Reddy YM, Di Biase L, Vanga SR, Santangeli P, Swarup V, Pimentel R, Mansour MC, D'Avila A, Sanchez JE, Burkhardt JD, Chalhoub F, Mohanty P, Coffey J, Shaik N, Monir G, Reddy VY, Ruskin J, Natale A.
    J Am Coll Cardiol; 2012 Mar 27; 59(13):1168-74. PubMed ID: 22305113
    [Abstract] [Full Text] [Related]

  • 5. [Impact of different anticoagulation therapies on heparin dosage applied to atrial fibrillation patients undergoing atrial fibrillation catheter ablation].
    Yang L, Gao LJ, Yin XM, Guo BL.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Aug 24; 47(8):602-607. PubMed ID: 31434430
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy of interrupted dabigatran for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis.
    Bin Abdulhak AA, Khan AR, Tleyjeh IM, Spertus JA, Sanders SU, Steigerwalt KE, Garbati MA, Bahmaid RA, Wimmer AP.
    Europace; 2013 Oct 24; 15(10):1412-20. PubMed ID: 23954918
    [Abstract] [Full Text] [Related]

  • 7. Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation.
    Dzeshka MS, Lip GY.
    Expert Opin Drug Saf; 2015 Jan 24; 14(1):45-62. PubMed ID: 25341529
    [Abstract] [Full Text] [Related]

  • 8. Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban.
    Winkle RA, Mead RH, Engel G, Kong MH, Patrawala RA.
    Europace; 2014 Oct 24; 16(10):1443-9. PubMed ID: 25115168
    [Abstract] [Full Text] [Related]

  • 9. Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation.
    Kim JS, She F, Jongnarangsin K, Chugh A, Latchamsetty R, Ghanbari H, Crawford T, Suwanagool A, Sinno M, Carrigan T, Kennedy R, Saint-Phard W, Yokokawa M, Good E, Bogun F, Pelosi F, Morady F, Oral H.
    Heart Rhythm; 2013 Apr 24; 10(4):483-9. PubMed ID: 23237911
    [Abstract] [Full Text] [Related]

  • 10. Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.
    Dans AL, Connolly SJ, Wallentin L, Yang S, Nakamya J, Brueckmann M, Ezekowitz M, Oldgren J, Eikelboom JW, Reilly PA, Yusuf S.
    Circulation; 2013 Feb 05; 127(5):634-40. PubMed ID: 23271794
    [Abstract] [Full Text] [Related]

  • 11. The budget impact of left atrial appendage closure compared with adjusted-dose warfarin and dabigatran etexilate for stroke prevention in atrial fibrillation.
    Amorosi SL, Armstrong S, Da Deppo L, Garfield S, Stein K.
    Europace; 2014 Aug 05; 16(8):1131-6. PubMed ID: 24687964
    [Abstract] [Full Text] [Related]

  • 12. Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses.
    Pink J, Lane S, Pirmohamed M, Hughes DA.
    BMJ; 2011 Oct 31; 343():d6333. PubMed ID: 22042753
    [Abstract] [Full Text] [Related]

  • 13. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
    Lip GY, Larsen TB, Skjøth F, Rasmussen LH.
    J Am Coll Cardiol; 2012 Aug 21; 60(8):738-46. PubMed ID: 22575324
    [Abstract] [Full Text] [Related]

  • 14. Safety and Efficacy of Minimally Interrupted Dabigatran vs Uninterrupted Warfarin Therapy in Adults Undergoing Atrial Fibrillation Catheter Ablation: A Randomized Clinical Trial.
    Nogami A, Harada T, Sekiguchi Y, Otani R, Yoshida Y, Yoshida K, Nakano Y, Nuruki N, Nakahara S, Goya M, Origasa H, Kihara Y, Hirao K, Aonuma K, ABRIDGE-J (ABlation peRIoperative DabiGatran in use Envisioning in Japan) Investigators.
    JAMA Netw Open; 2019 Apr 05; 2(4):e191994. PubMed ID: 31002317
    [Abstract] [Full Text] [Related]

  • 15. Dabigatran etexilate: a review of its use in the prevention of stroke and systemic embolism in patients with atrial fibrillation.
    Garnock-Jones KP.
    Am J Cardiovasc Drugs; 2011 Apr 05; 11(1):57-72. PubMed ID: 21265583
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation.
    Armbruster HL, Lindsley JP, Moranville MP, Habibi M, Khurram IM, Spragg DD, Berger RD, Calkins H, Marine JE.
    Ann Pharmacother; 2015 Mar 05; 49(3):278-84. PubMed ID: 25515868
    [Abstract] [Full Text] [Related]

  • 18. Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran.
    Ezekowitz MD, Connolly S, Parekh A, Reilly PA, Varrone J, Wang S, Oldgren J, Themeles E, Wallentin L, Yusuf S.
    Am Heart J; 2009 May 05; 157(5):805-10, 810.e1-2. PubMed ID: 19376304
    [Abstract] [Full Text] [Related]

  • 19. Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation.
    Maddox W, Kay GN, Yamada T, Osorio J, Doppalapudi H, Plumb VJ, Gunter A, McElderry HT.
    J Cardiovasc Electrophysiol; 2013 Aug 05; 24(8):861-5. PubMed ID: 23577951
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial.
    Wallentin L, Yusuf S, Ezekowitz MD, Alings M, Flather M, Franzosi MG, Pais P, Dans A, Eikelboom J, Oldgren J, Pogue J, Reilly PA, Yang S, Connolly SJ, RE-LY investigators.
    Lancet; 2010 Sep 18; 376(9745):975-83. PubMed ID: 20801496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.